Nuclear receptors and endobiotics glucuronidation: the good, the bad, and the UGT

References

• Aleksunes, L. M., Klaassen, C. D. (2012). Coordinated regulation of hepatic phase I and II drug-metabolizing genes and transporters using AhR-, CAR-, PXR-, PPARalpha-, and Nrf2-null mice. Drug Metab Dispos 40:1366–1379.
   PubMed Web of Science ®Google Scholar
• Arianayagam, M., Chang, J., Rashid, P. (2007). Chemotherapy in the treatment of prostate cancer—is there a role? Aust Fam Physician 36:737–739.
   PubMed Web of Science ®Google Scholar
• Aueviriyavit, S., Furihata, T., Morimoto, K., Kobayashi, K., Chiba, K. (2007). Hepatocyte nuclear factor 1 alpha and 4 alpha are factors involved in interindividual variability in the expression of UGT1A6 and UGT1A9 but not UGT1A1, UGT1A3 and UGT1A4 mRNA in human livers. Drug Metab Pharmacokinet 22:391–398.
   PubMed Web of Science ®Google Scholar
• Balk, S. P., Knudsen, K. E. (2008). AR, the cell cycle, and prostate cancer. Nucl Recept Signal 6:e001.
   PubMedGoogle Scholar
• Bancroft, J. D., Kreamer, B., Gourley, G. R. (1998). Gilbert syndrome accelerates development of neonatal jaundice. J Pediatr 132:656–660.
   PubMed Web of Science ®Google Scholar
• Bao, B. Y., Chuang, B. F., Wang, Q., Sartor, O., Balk, S. P., Brown, M., et al. (2008). Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes. Prostate 68:839–848.
   PubMed Web of Science ®Google Scholar
• Barbier, O. (2008). Nuclear receptor-mediated regulation of phase II conjugating enzymes. In: Xie, W. (ed.), Nuclear receptors in drug metabolism. Portland, Oregon, USA: Wiley & Sons.
   Google Scholar
• Barbier, O., Duran-Sandoval, D., Pineda-Torra, I., Kosykh, V., Fruchart, J. C., Staels, B. (2003a). Peroxisome proliferator-activated receptor alpha induces hepatic expression of the human bile acid glucuronidating UDP-glucuronosyltransferase 2B4 enzyme. J Biol Chem 278:32852–32860.
   PubMed Web of Science ®Google Scholar
• Barbier, O., Fontaine, C., Fruchart, J. C., Staels, B. (2004). Genomic and non-genomic interactions of PPARalpha with xenobiotic-metabolizing enzymes. Trends Endocrinol Metab 15:324–330.
   PubMed Web of Science ®Google Scholar
• Barbier, O., Girard, H., Inoue, Y., Duez, H., Villeneuve, L., Kamiya, A., et al. (2005). Hepatic expression of the UGT1A9 gene is governed by hepatocyte nuclear factor 4alpha. Mol Pharmacol 67:241–249.
   PubMed Web of Science ®Google Scholar
• Barbier, O., Torra, I. P., Sirvent, A., Claudel, T., Blanquart, C., Duran-Sandoval, D., et al. (2003b). FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity. Gastroenterology 124:1926–1940.
   PubMed Web of Science ®Google Scholar
• Barbier, O., Trottier, J., Kaeding, J., Caron, P., Verreault, M. (2009). Lipid-activated transcription factors control bile acid glucuronidation. Mol Cell Biochem 326:3–8.
   PubMed Web of Science ®Google Scholar
• Barbier, O., Villeneuve, L., Bocher, V., Fontaine, C., Torra, I. P., Duhem, C., et al. (2003c). The UDP-glucuronosyltransferase 1A9 enzyme is a peroxisome proliferator-activated receptor alpha and gamma target gene. J Biol Chem 278:13975–13983.
   PubMed Web of Science ®Google Scholar
• Beaulieu, M., Lévesque, E., Tchernof, A., Beatty, B. G., Bélanger, A., Hum, D. W. (1997). Chromosomal localization, structure, and regulation of the UGT2B17 gene, encoding a C19 steroid metabolizing enzyme. DNA Cell Biol 16:1143–1154.
   PubMed Web of Science ®Google Scholar
• Bélanger, A., Pelletier, G., Labrie, F., Barbier, O., Chouinard, S. (2003). Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans. Trends Endocrinol Metab 14:473–479.
   PubMed Web of Science ®Google Scholar
• Bellemare, J., Rouleau, M., Girard, H., Harvey, M., Guillemette, C. (2010a). Alternatively spliced products of the UGT1A gene interact with the enzymatically active proteins to inhibit glucuronosyltransferase activity in vitro. Drug Metab Dispos 38:1785–1789.
   PubMed Web of Science ®Google Scholar
• Bellemare, J., Rouleau, M., Harvey, M., Guillemette, C. (2010b). Modulation of the human glucuronosyltransferase UGT1A pathway by splice isoform polypeptides is mediated through protein-protein interactions. J Biol Chem 285:3600–3607.
   PubMed Web of Science ®Google Scholar
• Bellemare, J., Rouleau, M., Harvey, M., Tetu, B., Guillemette, C. (2010c). Alternative-splicing forms of the major phase II conjugating UGT1A gene negatively regulate glucuronidation in human carcinoma cell lines. Pharmacogenomics J 10:431–441.
   PubMed Web of Science ®Google Scholar
• Bernard, P., Goudonnet, H., Artur, Y., Desvergne, B., Wahli, W. (1999). Activation of the mouse TATA-less and human TATA-containing UDP-glucuronosyltransferase 1A1 promoters by hepatocyte nuclear factor 1. Mol Pharmacol 56:526–536.
   PubMed Web of Science ®Google Scholar
• Bock, K. W. (2012). Human UDP-glucuronosyltransferases: feedback loops between substrates and ligands of their transcription factors. Biochem Pharmacol 84:1000–1006.
   PubMed Web of Science ®Google Scholar
• Bosma, P. J. (2003). Inherited disorders of bilirubin metabolism. J Hepatol 38:107–117.
   PubMed Web of Science ®Google Scholar
• Breimer, L. H., Wannamethee, G., Ebrahim, S., Shaper, A. G. (1995). Serum bilirubin and risk of ischemic heart disease in middle-aged British men. Clin Chem 41:1504–1508.
   PubMed Web of Science ®Google Scholar
• Brites, D. (2011). Bilirubin injury to neurons and glial cells: new players, novel targets, and newer insights. Semin Perinatol 35:114–120.
   PubMed Web of Science ®Google Scholar
• Buckley, D. B., Klaassen, C. D. (2009). Induction of mouse UDP-glucuronosyltransferase mRNA expression in liver and intestine by activators of aryl-hydrocarbon receptor, constitutive androstane receptor, pregnane X receptor, peroxisome proliferator-activated receptor alpha, and nuclear factor erythroid 2-related factor 2. Drug Metab Dispos 37:847–856.
   PubMed Web of Science ®Google Scholar
• Chazouillères, O., Corpechot, C., Gaouar, F., Poupon, R. (2010). Fenofibrate improves liver tests in primary sclerosing cholangitis with incomplete biochemical response to ursodeoxycholic acid. In: AASLD (ed.), 61st Annual Meeting of the American Association for the Study of Liver Diseases. Boston, Massachusetts, USA, October 29–November 02, 2010.
   Google Scholar
• Chen, A. C., Petrylak, D. P. (2004). Complications of androgen deprivation therapy in men with prostate cancer. Curr Oncol Rep 6:209–215.
   PubMedGoogle Scholar
• Chen, H., Yang, K., Choi, S., Fischer, J. H., Jeong, H. (2009). Up-regulation of UDP-glucuronosyltransferase (UGT) 1A4 by 17beta-estradiol: a potential mechanism of increased lamotrigine elimination in pregnancy. Drug Metab Dispos 37:1841–1847.
   PubMed Web of Science ®Google Scholar
• Chen, S., Beaton, D., Nguyen, N., Senekeo-Effenberger, K., Brace-Sinnokrak, E., Argikar, U., et al. (2005). Tissue-specific, inducible, and hormonal control of the human UDP-glucuronosyltransferase-1 (UGT1) locus. J Biol Chem 280:37547–37557.
   PubMed Web of Science ®Google Scholar
• Chen, S., Yueh, M. F., Evans, R. M., Tukey, R. H. (2012). Pregnane-x-receptor controls hepatic glucuronidation during pregnancy and neonatal development in humanized UGT1 mice. Hepatology 56:658–667.
   PubMed Web of Science ®Google Scholar
• Chouinard, S., Barbier, O., Bélanger, A. (2007). UDP-glucuronosyltransferase (UGT)2B15 and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells. J Biol Chem 282:33466–33474.
   PubMed Web of Science ®Google Scholar
• Chouinard, S., Pelletier, G., Bélanger, A., Barbier, O. (2006). Isoform-specific regulation of uridine diphosphate-glucuronosyltransferase 2B enzymes in the human prostate: differential consequences for androgen and bioactive lipid inactivation. Endocrinology 147:5431–5442.
   PubMed Web of Science ®Google Scholar
• Chouinard, S., Yueh, M. F., Tukey, R. H., Giton, F., Fiet, J., Pelletier, G., et al. (2008). Inactivation by UDP-glucuronosyltransferase enzymes: the end of androgen signaling. J Steroid Biochem Mol Biol 109:247–253.
   PubMed Web of Science ®Google Scholar
• Cunha, G. R., Ricke, W., Thomson, A., Marker, P. C., Risbridger, G., Hayward, S. W., et al. (2004). Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development. J Steroid Biochem Mol Biol 92:221–236.
   PubMed Web of Science ®Google Scholar
• DePrimo, S. E., Diehn, M., Nelson, J. B., Reiter, R. E., Matese, J., Fero, M., et al. (2002). Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biol 3:320–332.
   Google Scholar
• Djousse, L., Levy, D., Cupples, L. A., Evans, J. C., D’Agostino, R. B., Ellison, R. C. (2001). Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol 87:1196–1200.
   PubMed Web of Science ®Google Scholar
• Dohmen, K., Mizuta, T., Nakamuta, M., Shimohashi, N., Ishibashi, H., Yamamoto, K. (2004). Fenofibrate for patients with asymptomatic primary biliary cirrhosis. World J Gastroenterol 10:894–898.
   PubMed Web of Science ®Google Scholar
• Dutton, G. J. (1980). Glucuronidation of drugs and other compounds. Boca Raton, Florida, USA: CRC.
   Google Scholar
• Ehmer, U., Kalthoff, S., Lankisch, T. O., Freiberg, N., Manns, M. P., Strassburg, C. P. (2010). Shared regulation of UGT1A7 by hepatocyte nuclear factor (HNF) 1alpha and HNF4alpha. Drug Metab Dispos 38:1246–1257.
   PubMed Web of Science ®Google Scholar
• Eirís-Punal, J., Del Río-Garma, M., Del Rio-Garma, M. C., Lojo-Rocamonde, S., Novo-Rodríguez, I., Castro-Gago, M. (1999). Long-term treatment of children with epilepsy with valproate or carbamazepine may cause subclinical hypothyroidism. Epilepsia 40:1761–1766.
   PubMed Web of Science ®Google Scholar
• Emi, Y., Ikushiro, S., Kato, Y. (2007). Thyroxine-metabolizing rat uridine diphosphate-glucuronosyltransferase 1A7 is regulated by thyroid hormone receptor. Endocrinology 148:6124–6133.
   PubMed Web of Science ®Google Scholar
• Erichsen, T. J., Aehlen, A., Ehmer, U., Kalthoff, S., Manns, M. P., Strassburg, C. P. (2010). Regulation of the human bile acid UDP-glucuronosyltransferase 1A3 by the farnesoid X receptor and bile acids. J Hepatol 52:570–578.
   PubMed Web of Science ®Google Scholar
• Fretzayas, A., Moustaki, M., Liapi, O., Karpathios, T. (2012). Gilbert syndrome. Eur J Pediatr 171:11–15.
   PubMed Web of Science ®Google Scholar
• Gao, J., Xie, W. (2010). Pregnane X receptor and constitutive androstane receptor at the crossroads of drug metabolism and energy metabolism. Drug Metab Dispos 38:2091–2095.
   PubMed Web of Science ®Google Scholar
• Gardner-Stephen, D., Heydel, J. M., Goyal, A., Lu, Y., Xie, W., Lindblom, T., et al. (2004). Human PXR variants and their differential effects on the regulation of human UDP-glucuronosyltransferase gene expression. Drug Metab Dispos 32:340–347.
   PubMed Web of Science ®Google Scholar
• Gardner-Stephen, D. A., Mackenzie, P. I. (2007a). Hepatocyte nuclear factor1 transcription factors are essential for the UDP-glucuronosyltransferase 1A9 promoter response to hepatocyte nuclear factor 4alpha. Pharmacogenet Genomics 17:25–36.
   PubMed Web of Science ®Google Scholar
• Gardner-Stephen, D. A., Mackenzie, P. I. (2007b). Isolation of the UDP-glucuronosyltransferase 1A3 and 1A4 proximal promoters and characterization of their dependence on the transcription factor hepatocyte nuclear factor 1alpha. Drug Metab Dispos 35:116–120.
   PubMed Web of Science ®Google Scholar
• Girard, H., Lévesque, E., Bellemare, J., Journault, K., Caillier, B., Guillemette, C. (2007). Genetic diversity at the UGT1 locus is amplified by a novel 3′ alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activity. Pharmacogenet Genomics 17:1077–1089.
   PubMed Web of Science ®Google Scholar
• Glass, C. K. (1994). Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocr Rev 15:391–407.
   PubMed Web of Science ®Google Scholar
• Gregory, P. A., Hansen, A. J., Mackenzie, P. I. (2000). Tissue specific differences in the regulation of the UDP glucuronosyltransferase 2B17 gene promoter. Pharmacogenetics, 10:809–820.
   PubMedGoogle Scholar
• Gregory, P. A., Lewinsky, R. H., Gardner-Stephen, D. A., Mackenzie, P. I. (2004). Coordinate regulation of the human UDP-glucuronosyltransferase 1A8, 1A9, and 1A10 genes by hepatocyte nuclear factor 1alpha and the caudal-related homeodomain protein 2. Mol Pharmacol 65:953–963.
   PubMed Web of Science ®Google Scholar
• Gu, Y. Z., Hogenesch, J. B., Bradfield, C. A. (2000). The PAS superfamily: sensors of environmental and developmental signals. Annu Rev Pharmacol Toxicol 40:519–561.
   PubMed Web of Science ®Google Scholar
• Guillemette, C., Lévesque, E., Beaulieu, M., Turgeon, D., Hum, D. W., Bélanger, A. (1997). Differential regulation of two uridine diphospho-glucuronosyltransferases, UGT2B15 and UGT2B17, in human prostate LNCaP cells. Endocrinology 138:2998–3005.
   PubMed Web of Science ®Google Scholar
• Guillemette, C., Lévesque, E., Harvey, M., Bellemare, J., Ménard, V. (2010). UGT genomic diversity: beyond gene duplication. Drug Metab Rev 42:24–44.
   PubMed Web of Science ®Google Scholar
• Hadaschik, B. A., Gleave, M. E. (2007). Therapeutic options for hormone-refractory prostate cancer in 2007. Urol Oncol 25:413–419.
   PubMed Web of Science ®Google Scholar
• Hankinson, O. (1995). The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol 35:307–340.
   PubMed Web of Science ®Google Scholar
• Hu, D. G., Mackenzie, P. I. (2009). Estrogen receptor alpha, fos-related antigen-2, and c-Jun coordinately regulate human UDP glucuronosyltransferase 2B15 and 2B17 expression in response to 17beta-estradiol in MCF-7 cells. Mol Pharmacol 76:425–439.
   PubMed Web of Science ®Google Scholar
• Huang, W., Zhang, J., Chua, S. S., Qatanani, M., Han, Y., Granata, R., et al. (2003). Induction of bilirubin clearance by the constitutive androstane receptor (CAR). Proc Natl Acad Sci USA 100:4156–4161.
   PubMed Web of Science ®Google Scholar
• Hunt, S. C., Kronenberg, F., Eckfeldt, J. H., Hopkins, P. N., Myers, R. H., Heiss, G. (2001). Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: the NHLBI family heart study. Atherosclerosis 154:747–754.
   PubMed Web of Science ®Google Scholar
• Iida, K., Mimura, J., Itoh, K., Ohyama, C., Fujii-Kuriyama, Y., Shimazui, T., et al. (2010). Suppression of AhR signaling pathway is associated with the down-regulation of UDP-glucuronosyltransferases during BBN-induced urinary bladder carcinogenesis in mice. J Biochem 147:353–360.
   PubMed Web of Science ®Google Scholar
• Ishii, Y., Hansen, A. J., Mackenzie, P. I. (2000). Octamer transcription factor-1 enhances hepatic nuclear factor-1alpha-mediated activation of the human UDP glucuronosyltransferase 2B7 promoter. Mol Pharmacol 57:940–947.
   PubMed Web of Science ®Google Scholar
• Iwasaki, S., Ohira, H., Nishiguchi, S., Zeniya, M., Kaneko, S., Onji, M., et al. (2008). The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: A prospective, multicenter study. Hepatol Res 38:557–564.
   PubMed Web of Science ®Google Scholar
• Izumi, K., Zheng, Y., Hsu, J. W., Chang, C., Miyamoto, H. (2011). Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: a potential mechanism of androgen-induced bladder carcinogenesis. Mol Carcinog Nov 15 (epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Jansen, P. L. (1999). Diagnosis and management of Crigler-Najjar syndrome. Eur J Pediatr 158(Suppl 2):S89–S94.
   PubMed Web of Science ®Google Scholar
• Jedlitschky, G., Cassidy, A. J., Sales, M., Pratt, N., Burchell, B. (1999). Cloning and characterization of a novel human olfactory UDP-glucuronosyltransferase. Biochem J, 340(Pt 3):837–843.
   PubMed Web of Science ®Google Scholar
• Kaeding, J., Bélanger, J., Caron, P., Verreault, M., Bélanger, A., Barbier, O. (2008a). Calcitrol (1alpha,25-dihydroxyvitamin D3) inhibits androgen glucuronidation in prostate cancer cells. Mol Cancer Ther 7:380–390.
   PubMed Web of Science ®Google Scholar
• Kaeding, J., Bouchaert, E., Bélanger, J., Caron, P., Chouinard, S., Verreault, M., et al. (2008b). Activators of the farnesoid X receptor negatively regulate androgen glucuronidation in human prostate cancer LNCAP cells. Biochem J 410:245–253.
   PubMed Web of Science ®Google Scholar
• Kapitulnik, J., Gonzalez, F. J. (1993). Marked endogenous activation of the CYP1A1 and CYP1A2 genes in the congenitally jaundiced Gunn rat. Mol Pharmacol 43:722–725.
   PubMed Web of Science ®Google Scholar
• Keppler, D. (2011). Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy. Handb Exp Pharmacol 299–323.
   PubMedGoogle Scholar
• King, C. D., Rios, G. R., Green, M. D., Tephly, T. R. (2000). UDP-glucuronosyltransferases. Curr Drug Metab 1:143–161.
   PubMed Web of Science ®Google Scholar
• Klaassen, C. D., Hood, A. M. (2001). Effects of microsomal enzyme inducers on thyroid follicular cell proliferation and thyroid hormone metabolism. Toxicol Pathol 29:34–40.
   PubMed Web of Science ®Google Scholar
• Konishi, N., Shimada, K., Ishida, E., Nakamura, M. (2005). Molecular pathology of prostate cancer. Pathol Int 55:531–539.
   PubMed Web of Science ®Google Scholar
• Kronenberg, F., Coon, H., Gutin, A., Abkevich, V., Samuels, M. E., Ballinger, D. G., et al. (2002). A genome scan for loci influencing anti-atherogenic serum bilirubin levels. Eur J Hum Genet 10:539–546.
   PubMed Web of Science ®Google Scholar
• Kuno, T., Togawa, H., Mizutani, T. (2008). Induction of human UGT1A1 by a complex of dexamethasone-GR dependent on proximal site and independent of PBREM. Mol Biol Rep 35:361–367.
   PubMed Web of Science ®Google Scholar
• Labrie, F., Bélanger, A., Luu-The, V., Labrie, C., Simard, J., Cusan, L., et al. (2005). Gonadotropin-releasing hormone agonists in the treatment of prostate cancer. Endocr Rev 26:361–379.
   PubMed Web of Science ®Google Scholar
• Lam, J. S., Leppert, J. T., Vemulapalli, S. N., Shvarts, O., Belldegrun, A. S. (2006). Secondary hormonal therapy for advanced prostate cancer. J Urol 175:27–34.
   PubMed Web of Science ®Google Scholar
• Lankisch, T. O., Gillman, T. C., Erichsen, T. J., Ehmer, U., Kalthoff, S., Freiberg, N., et al. (2008). Aryl hydrocarbon receptor-mediated regulation of the human estrogen and bile acid UDP-glucuronosyltransferase 1A3 gene. Arch Toxicol 82:573–582.
   PubMed Web of Science ®Google Scholar
• Lévesque, E., Beaulieu, M., Guillemette, C., Hum, D. W., Bélanger, A. (1998a). Effect of fibroblastic growth factors (FGF) on steroid UDP-glucuronosyltransferase expression and activity in the LNCaP cell line. J Steroid Biochem Mol Biol 64:43–48.
   PubMed Web of Science ®Google Scholar
• Lévesque, E., Beaulieu, M., Guillemette, C., Hum, D. W., Bélanger, A. (1998b). Effect of interleukins on UGT2B15 and UGT2B17 steroid uridine diphosphate-glucuronosyltransferase expression and activity in the LNCaP cell line. Endocrinology 139:2375–2381.
   PubMed Web of Science ®Google Scholar
• Lévesque, E., Girard, H., Journault, K., Lépine, J., Guillemette, C. (2007). Regulation of the UGT1A1 bilirubin-conjugating pathway: role of a new splicing event at the UGT1A locus. Hepatology 45:128–138.
   PubMed Web of Science ®Google Scholar
• Lévesque, E., Ménard, V., Laverdière, I., Bellemare, J., Barbier, O., Girard, H., et al. (2010). Extensive splicing of transcripts encoding the bile acid-conjugating enzyme UGT2B4 modulates glucuronidation. Pharmacogenet Genomics 20:195–210.
   PubMed Web of Science ®Google Scholar
• Levy, C., Peter, J. A., Nelson, D. R., Keach, J., Petz, J., Cabrera, R., et al. (2011). Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid. Aliment Pharmacol Ther 33:235–242.
   PubMed Web of Science ®Google Scholar
• Li, Y. Q., Prentice, D. A., Howard, M. L., Mashford, M. L., Desmond, P. V. (2000). Bilirubin and bile acids may modulate their own metabolism via regulating uridine diphosphate-glucuronosyltransferase expression in the rat. J Gastroenterol Hepatol 15:865–870.
   PubMed Web of Science ®Google Scholar
• Little, J. M., Williams, L., Xu, J., Radominska-Pandya, A. (2002). Glucuronidation of the dietary fatty acids, phytanic acid and docosahexaenoic acid, by human UDP-glucuronosyltransferases. Drug Metab Dispos 30:531–533.
   PubMed Web of Science ®Google Scholar
• Litvinov, I. V., De Marzo, A. M., Isaacs, J. T. (2003). Is the Achilles’ heel for prostate cancer therapy a gain of function in androgen receptor signaling? J Clin Endocrinol Metab 88:2972–2982.
   PubMed Web of Science ®Google Scholar
• Lu, Y., Bratton, S., Heydel, J. M., Radominska-Pandya, A. (2008). Effect of retinoids on UDP-glucuronosyltransferase 2B7 mRNA expression in Caco-2 cells. Drug Metab Pharmacokinet 23:364–372.
   PubMed Web of Science ®Google Scholar
• Lu, Y., Heydel, J. M., Li, X., Bratton, S., Lindblom, T., Radominska-Pandya, A. (2005). Lithocholic acid decreases expression of UGT2B7 in Caco-2 cells: a potential role for a negative farnesoid X receptor response element. Drug Metab Dispos 33:937–946.
   PubMed Web of Science ®Google Scholar
• Maglich, J. M., Watson, J., McMillen, P. J., Goodwin, B., Willson, T. M., Moore, J. T. (2004). The nuclear receptor CAR is a regulator of thyroid hormone metabolism during caloric restriction. J Biol Chem 279:19832–19838.
   PubMed Web of Science ®Google Scholar
• Meech, R., Mackenzie, P. I. (1997). Structure and function of uridine diphosphate glucuronosyltransferases. Clin Exp Pharmacol Physiol 24:907–915.
   PubMed Web of Science ®Google Scholar
• Ménard, V., Eap, O., Roberge, J., Harvey, M., Lévesque, E., Guillemette, C. (2011). Transcriptional diversity at the UGT2B7 locus is dictated by extensive pre-mRNA splicing mechanisms that give rise to multiple mRNA splice variants. Pharmacogenet Genomics 21:631–641.
   PubMed Web of Science ®Google Scholar
• Mohler, J. L., Gregory, C. W., Ford, O. H., III, Kim, D., Weaver, C. M., Petrusz, P., et al. (2004). The androgen axis in recurrent prostate cancer. Clin Cancer Res 10:440–448.
   PubMed Web of Science ®Google Scholar
• Monte, M. J., Marin, J. J., Antelo, A., Vazquez-Tato, J. (2009). Bile acids: chemistry, physiology, and pathophysiology. World J Gastroenterol 15:804–816.
   PubMed Web of Science ®Google Scholar
• Moore, J. T., Collins, J. L., Pearce, K. H. (2006). The nuclear receptor superfamily and drug discovery. ChemMedChem 1:504–523.
   PubMed Web of Science ®Google Scholar
• Munzel, P. A., Schmohl, S., Buckler, F., Jaehrling, J., Raschko, F. T., Kohle, C., et al. (2003). Contribution of the Ah receptor to the phenolic antioxidant-mediated expression of human and rat UDP-glucuronosyltransferase UGT1A6 in Caco-2 and rat hepatoma 5L cells. Biochem Pharmacol 66:841–847.
   PubMed Web of Science ®Google Scholar
• Nadeau, G., Bellemare, J., Audet-Walsh, E., Flageole, C., Huang, S. P., Bao, B. Y., et al. (2011). Deletions of the androgen-metabolizing UGT2B genes have an effect on circulating steroid levels and biochemical recurrence after radical prostatectomy in localized prostate cancer. J Clin Endocrinol Metab 96:E1550–E1557.
   PubMed Web of Science ®Google Scholar
• Nakai, S., Masaki, T., Kurokohchi, K., Deguchi, A., Nishioka, M. (2000). Combination therapy of bezafibrate and ursodeoxycholic acid in primary biliary cirrhosis: a preliminary study. Am J Gastroenterol 95:326–327.
   PubMed Web of Science ®Google Scholar
• Nakata, K., Tanaka, Y., Nakano, T., Adachi, T., Tanaka, H., Kaminuma, T., et al. (2006). Nuclear receptor-mediated transcriptional regulation in phase I, II, and III xenobiotic metabolizing systems. Drug Metab Pharmacokinet 21:437–457.
   PubMed Web of Science ®Google Scholar
• Nebert, D. W. (1991). Proposed role of drug-metabolizing enzymes: regulation of steady state levels of the ligands that effect growth, homeostasis, differentiation, and neuroendocrine functions. Mol Endocrinol 5:1203–1214.
   PubMed Web of Science ®Google Scholar
• Nelson, P. S., Clegg, N., Arnold, H., Ferguson, C., Bonham, M., White, J., et al. (2002). The program of androgen-responsive genes in neoplastic prostate epithelium. Proc Natl Acad Sci USA 99:11890–11905.
   PubMed Web of Science ®Google Scholar
• Ohira, H., Sato, Y., Ueno, T., Sata, M. (2002). Fenofibrate treatment in patients with primary biliary cirrhosis. Am J Gastroenterol 97:2147–2149.
   PubMed Web of Science ®Google Scholar
• Olinga, P., Elferink, M. G., Draaisma, A. L., Merema, M. T., Castell, J. V., Perez, G., et al. (2008). Coordinated induction of drug transporters and phase I and II metabolism in human liver slices. Eur J Pharm Sci 33:380–389.
   PubMed Web of Science ®Google Scholar
• Olsson, M., Ekstrom, L., Guillemette, C., Bélanger, A., Rane, A., Gustafsson, O. (2011). Correlation between circulatory, local prostatic, and intra-prostatic androgen levels. Prostate 71:909–914.
   PubMed Web of Science ®Google Scholar
• Ottow, E., Weinmann, H. (2008). Nuclear receptors as drug targets: a historical perspective of modern drug discovery. In: Weinmann, E. O. A. H. (ed.), Nuclear receptors as drug targets. Weinheim, Germany: Wiley-VCH Verlag.
   Google Scholar
• Owens, I. S., Basu, N. K., Banerjee, R. (2005). UDP-glucuronosyltransferases: gene structures of UGT1 and UGT2 families. Methods Enzymol 400:1–22.
   PubMed Web of Science ®Google Scholar
• Paquet, S., Fazli, L., Grosse, L., Verreault, M., Tetu, B., Rennie, P. S., et al. (2012). Differential expression of the androgen-conjugating UGT2B15 and UGT2B17 enzymes in prostate tumor cells during cancer progression. J Clin Endocrinol Metab 97:E428–E432.
   PubMed Web of Science ®Google Scholar
• Pascussi, J. M., Gerbal-Chaloin, S., Duret, C., Daujat-Chavanieu, M., Vilarem, M. J., Maurel, P. (2008). The tangle of nuclear receptors that controls xenobiotic metabolism and transport: crosstalk and consequences. Annu Rev Pharmacol Toxicol 48:1–32.
   PubMed Web of Science ®Google Scholar
• Pauli-Magnus, C., Meier, P. J. (2005). Hepatocellular transporters and cholestasis. J Clin Gastroenterol 39:S103–S110.
   PubMed Web of Science ®Google Scholar
• Paumgartner, G. (2010). Pharmacotherapy of cholestatic liver diseases. J Dig Dis 11:119–125.
   PubMed Web of Science ®Google Scholar
• Phelan, D., Winter, G. M., Rogers, W. J., Lam, J. C., Denison, M. S. (1998). Activation of the Ah receptor signal transduction pathway by bilirubin and biliverdin. Arch Biochem Biophys 357:155–163.
   PubMed Web of Science ®Google Scholar
• Qatanani, M., Zhang, J., Moore, D. D. (2005). Role of the constitutive androstane receptor in xenobiotic-induced thyroid hormone metabolism. Endocrinology 146:995–1002.
   PubMed Web of Science ®Google Scholar
• Radominska-Pandya, A., Czernik, P. J., Little, J. M., Battaglia, E., Mackenzie, P. I. (1999). Structural and functional studies of UDP-glucuronosyltransferases. Drug Metab Rev 31:817–899.
   PubMed Web of Science ®Google Scholar
• Riedy, M., Wang, J. Y., Miller, A. P., Buckler, A., Hall, J., Guida, M. (2000). Genomic organization of the UGT2b gene cluster on human chromosome 4q13. Pharmacogenetics 10:251–260.
   PubMedGoogle Scholar
• Saini, S. P., Mu, Y., Gong, H., Toma, D., Uppal, H., Ren, S., et al. (2005). Dual role of orphan nuclear receptor pregnane X receptor in bilirubin detoxification in mice. Hepatology 41:497–505.
   PubMed Web of Science ®Google Scholar
• Schwertner, H. A. (2003). Bilirubin concentration, UGT1A1*28 polymorphism, and coronary artery disease. Clin Chem 49:1039–1040.
   PubMed Web of Science ®Google Scholar
• Schwertner, H. A., Vitek, L. (2008). Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin. Atherosclerosis 198:1–11.
   PubMed Web of Science ®Google Scholar
• Senekeo-Effenberger, K., Chen, S., Brace-Sinnokrak, E., Bonzo, J. A., Yueh, M. F., Argikar, U., et al. (2007). Expression of the human UGT1 locus in transgenic mice by 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic acid (WY-14643) and implications on drug metabolism through peroxisome proliferator-activated receptor alpha activation. Drug Metab Dispos 35:419–427.
   PubMed Web of Science ®Google Scholar
• Seppen, J., Bosma, P. J., Goldhoorn, B. G., Bakker, C. T., Chowdhury, J. R., Chowdhury, N. R., et al. (1994). Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphate-glucuronosyltransferase. J Clin Invest 94:2385–2391.
   PubMed Web of Science ®Google Scholar
• Shaneyfelt, T., Husein, R., Bubley, G., Mantzoros, C. S. (2000). Hormonal predictores of prostate cancer: a meta-analysis. J Clin Oncol 18:847–853.
   PubMed Web of Science ®Google Scholar
• Shapiro, S. M. (2010). Chronic bilirubin encephalopathy: diagnosis and outcome. Semin Fetal Neonatal Med 15:157–163.
   PubMed Web of Science ®Google Scholar
• Sharifi, N., Gulley, J. L., Dahut, W. L. (2005). Androgen deprivation therapy for prostate cancer. JAMA 294:238–244.
   PubMed Web of Science ®Google Scholar
• Sherman, M. H., Downes, M., Evans, R. M. (2012). Nuclear receptors as modulators of the tumor microenvironment. Cancer Prev Res (Phila) 5:3–10.
   PubMed Web of Science ®Google Scholar
• Stanley, L. A., Horsburgh, B. C., Ross, J., Scheer, N., Wolf, C. R. (2006). PXR and CAR: nuclear receptors which play a pivotal role in drug disposition and chemical toxicity. Drug Metab Rev 38:515–597.
   PubMed Web of Science ®Google Scholar
• Starlard-Davenport, A., Lyn-Cook, B., Radominska-Pandya, A. (2008). Novel identification of UDP-glucuronosyltransferase 1A10 as an estrogen-regulated target gene. Steroids 73:139–147.
   PubMed Web of Science ®Google Scholar
• Stocker, R., Yamamoto, Y., McDonagh, A. F., Glazer, A. N., Ames, B. N. (1987). Bilirubin is an antioxidant of possible physiological importance. Science 235:1043–1046.
   PubMed Web of Science ®Google Scholar
• Sueyoshi, T., Negishi, M. (2001). Phenobarbital response elements of cytochrome P450 genes and nuclear receptors. Annu Rev Pharmacol Toxicol 41:123–143.
   PubMed Web of Science ®Google Scholar
• Sugatani, J., Sueyoshi, T., Negishi, M., Miwa, M. (2005). Regulation of the human UGT1A1 gene by nuclear receptors constitutive active/androstane receptor, pregnane X receptor, and glucocorticoid receptor. Methods Enzymol 400:92–104.
   PubMed Web of Science ®Google Scholar
• Sugatani, J., Yamakawa, K., Tonda, E., Nishitani, S., Yoshinari, K., Degawa, M., et al. (2004). The induction of human UDP-glucuronosyltransferase 1A1 mediated through a distal enhancer module by flavonoids and xenobiotics. Biochem Pharmacol 67:989–1000.
   PubMed Web of Science ®Google Scholar
• Temme, E. H., Zhang, J., Schouten, E. G., Kesteloot, H. (2001). Serum bilirubin and 10-year mortality risk in a Belgian population. Cancer Causes Control 12:887–894.
   PubMed Web of Science ®Google Scholar
• Togawa, H., Shinkai, S., Mizutani, T. (2008). Induction of human UGT1A1 by bilirubin through AhR dependent pathway. Drug Metab Lett 2:231–237.
   PubMedGoogle Scholar
• Trottier, J., Caron, P., Straka, R. J., Barbier, O. (2011). Profile of serum bile acids in noncholestatic volunteers: gender-related differences in response to fenofibrate. Clin Pharmacol Ther 90:279–286.
   PubMed Web of Science ®Google Scholar
• Trottier, J., Milkiewicz, P., Kaeding, J., Verreault, M., Barbier, O. (2006a). Coordinate regulation of hepatic bile acid oxidation and conjugation by nuclear receptors. Mol Pharm 3:212–222.
   PubMedGoogle Scholar
• Trottier, J., Verreault, M., Grepper, S., Monté, D., Bélanger, J., Kaeding, J., et al. (2006b). Human UDP-glucuronosyltransferase (UGT)1A3 enzyme conjugates chenodeoxycholic in the liver. Hepatology 44:1158–1170.
   PubMed Web of Science ®Google Scholar
• Turgeon, D., Carrier, J. S., Lévesque, E., Beatty, B. G., Bélanger, A., Hum, D. W. (2000). Isolation and characterization of the human UGT2B15 gene, localized within a cluster of UGT2B genes and pseudogenes on chromosome 4. J Mol Biol 295:489–504.
   PubMed Web of Science ®Google Scholar
• Tzameli, I., Moore, D. D. (2001). Role reversal: new insights from new ligands for the xenobiotic receptor CAR. Trends Endocrinol Metab 12:7–10.
   PubMed Web of Science ®Google Scholar
• Verreault, M., Kaeding, J., Caron, P., Trottier, J., Grosse, L., Houssin, E., et al. (2010). Regulation of endobiotics glucuronidation by ligand-activated transcription factors: physiological function and therapeutic potential. Drug Metab Rev 42:110–122.
   PubMed Web of Science ®Google Scholar
• Verreault, M., Senekeo-Effenberger, K., Trottier, J., Bonzo, J. A., Bélanger, J., Kaeding, J., et al. (2006). The liver X-receptor alpha controls hepatic expression of the human bile acid-glucuronidating UGT1A3 enzyme in human cells and transgenic mice. Hepatology 44:368–378.
   PubMed Web of Science ®Google Scholar
• Vitek, L., Jirsa, M., Brodanova, M., Kalab, M., Marecek, Z., Danzig, V., et al. (2002). Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis 160:449–456.
   PubMed Web of Science ®Google Scholar
• Watson, P. A., Chen, Y. F., Balbas, M. D., Wongvipat, J., Socci, N. D., Viale, A., et al. (2010). Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor. Proc Natl Acad Sci USA 107:16759–16765.
   PubMed Web of Science ®Google Scholar
• Wei, M., Schwertner, H. A., Zeng, Q., Blair, S. N. (2000). Fasting serum bilirubin concentrations and the risk of subsequent coronary heart disease death in men. Hepatology 32:314A.
   Web of Science ®Google Scholar
• Wells, P. G., Mackenzie, P. I., Chowdhury, J. R., Guillemette, C., Gregory, P. A., Ishii, Y., et al. (2004). Glucuronidation and the UDP-glucuronosyltransferases in health and disease. Drug Metab Dispos 32:281–290.
   PubMed Web of Science ®Google Scholar
• Westerink, W. M., Schoonen, W. G. (2007). Phase II enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells. Toxicol In Vitro 21:1592–1602.
   PubMed Web of Science ®Google Scholar
• Yeager, R. L., Reisman, S. A., Aleksunes, L. M., Klaassen, C. D. (2009). Introducing the “TCDD-inducible AhR-Nrf2 gene battery”. Toxicol Sci 111:238–246.
   PubMed Web of Science ®Google Scholar
• Yueh, M. F., Bonzo, J. A., Tukey, R. H. (2005). The role of Ah receptor in induction of human UDP-glucuronosyltransferase 1A1. Methods Enzymol 400:75–91.
   PubMed Web of Science ®Google Scholar
• Yueh, M. F., Huang, Y. H., Hiller, A., Chen, S., Nguyen, N., Tukey, R. H. (2003). Involvement of the xenobiotic response element (XRE) in Ah receptor-mediated induction of human UDP-glucuronosyltransferase 1A1. J Biol Chem 278:15001–15006.
   PubMed Web of Science ®Google Scholar
• Yueh, M. F., Tukey, R. H. (2007). Nrf2-Keap1 signaling pathway regulates human UGT1A1 expression in vitro and in transgenic UGT1 mice. J Biol Chem 282:8749–8758.
   PubMed Web of Science ®Google Scholar